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Summary
Imbalances in neurotrophins or their high-affinity Trk
receptors have long been reported in neurodegen-
erative diseases. However, a molecular link between
these gene products and neuronal cell death has not
been established. In the trisomy 16 (Ts16) mouse
there is increased apoptosis in the cortex, and hippo-
campal neurons undergo accelerated cell death that
cannot be rescued by administration of brain-derived
neurotrophic factor (BDNF). Ts16 neurons have nor-
mal levels of the TrkB tyrosine kinase receptor but
an upregulation of the TrkB.T1 truncated receptor iso-
form. Here we show that restoration of the physiolog-
ical level of the TrkB.T1 receptor by gene targeting
rescues Ts16 cortical cell and hippocampal neuronal
death. Moreover, it corrects resting Ca2+ levels and re-
stores BDNF-induced intracellular signaling mediated
by full-length TrkB in Ts16 hippocampal neurons.
These data provide a direct link between neuronal
cell death and abnormalities in Trk neurotrophin re-
ceptor levels.
Introduction
Linking specific genes to developmental or pathological
conditions is one of the most challenging tasks in exper-
imental biology. While gene targeting can identify the
direct involvement of a gene in a specific developmental
process, in pathological conditions, this task is much
more complex due to the numerous alterations in gene
or protein expression levels that are associated with
the disease. Most studies are correlative, and rarely
can an unambiguous connection between a gene prod-
uct and a phenotype be established. One successful ex-
ample is Huntington’s disease, where numerous lines of
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more, Maryland.evidence supported the notion that a mutated huntingtin
fragment was the cause of the disease, and a causal re-
lationship between mutant protein expression and pro-
gression of the pathology was shown with a conditional
mouse model where the blockade of expression of the
mutant protein in symptomatic mice lead to the disap-
pearance of inclusions and the amelioration of the be-
havioral phenotype (Yamamoto et al., 2000).
Neurotrophins and their receptors are critical for nor-
mal nervous system development (Bibel and Barde,
2000; Huang and Reichardt, 2001; Snider, 1994; Tessar-
ollo, 1998). Changes in their expression have been re-
ported in a variety of pathological conditions, including
neurodegenerative diseases (Connor et al., 1996; Daw-
barn and Allen, 2003; Ferrer et al., 1999). However, while
they have been considered targets for clinical interven-
tion, their direct role in causing pathologies of the ner-
vous system is still unclear. Neurotrophin heterozygous
mice have been a useful system to investigate the ef-
fects of reducing neurotrophin levels in the adult, which
include obesity and increased aggression in BDNF+/2
mice and memory deficits in NGF+/2 mice (Chen et al.,
1997; Lyons et al., 1999). However, to date, there is no
information on whether dysregulation of Trk receptor
isoforms, often observed in pathological conditions,
may affect neuronal physiology (Dawbarn and Allen,
2003; Ferrer et al., 1999). Neurons from the trisomy 16
(Ts16) mouse represent a useful model to study the
effects of dysregulation of a variety of genes and its
relative impact on neuronal survival (Coyle et al., 1991).
Ex vivo, hippocampal neurons undergo accelerated
cell death that can be rescued by a variety of exogenous
factors, including fibroblast growth factor 2 and neuro-
trophin-3 (Dorsey et al., 2002). However, in these rescue
experiments it is difficult to identify the primary defects
leading to cell death because pharmacological activa-
tion of strong prosurvival pathways could mask the
intrinsic cellular defect.
We previously reported that the accelerated death of
Ts16 neurons could be prevented by exogenous NT-3,
but not BDNF, a potent autocrine survival factor for nor-
mal hippocampal neurons, demonstrating a selective
defect in BDNF responsiveness (Dorsey et al., 2002).
Ts16 neurons overexpress the T1 isoform of truncated
TrkB (TrkB.T1), and the premature hippocampal neuron
cell death could be rescued by overexpression of the
full-length, catalytically active isoform of TrkB. Since
TrkB.T1 can act as a dominant-negative inhibitor of
BDNF signaling via full-length TrkB (Eide et al., 1996),
TrkB.T1 overexpression may cause the accelerated
death of Ts16 neurons.
In this study, we used a gene-targeting approach to
reduce TrkB.T1 to physiological levels in theTs16mouse
in order to test the hypothesis that overexpression of
TrkB.T1 is the primary cause of the accelerated Ts16
hippocampal neuron death in vitro and increased neuro-
nal apoptosis in vivo. We found that genetic reduction
of TrkB.T1 expression to a physiological level rescues
neuron cell death both in vitro and in vivo. This res-
cue is associated with a restoration of TrkB and Akt
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ization of resting Ca2+ levels in neurons. Our results sug-
gest that alterations of receptor isoform expression can
affect neurotrophin signaling and consequently neuron
survival. Small alterations in neurotrophin/Trk receptor
activation like those seen in mouse Ts16 may be directly
linked to neurodegenerative diseases.
Figure 1. TrkB.T1 Deletion Does Not Affect Full-Length TrkB Ex-
pression
(A) Diagram of the TrkB locus showing the position of the TrkB.T1-
specific coding exon relative to the exons encoding the tyrosine
kinase catalytic domain. (B) Schematic representation of the re-
placement type vector and strategy used to delete the TrkB.T1
exon. Restriction enzyme sites are as indicated. B, BamHI; S,
SpeI. pBS indicates the pBluescript cloning vector. Southern blot
analysis of ES cell DNA using an SpeI digest and probe A detected
the rearrangement in the mouse TrkB locus (not shown). (C) South-
ern blot analysis of tail DNA from a litter obtained by intercrossing
a TrkB.T1-NEO+/2 mouse with a b-actin CRE+/+ mouse, using
a BamHI digest and probe B shown in panel (A). Note the switch
of the 3 kb band (center lane) to 3.4 kb (right lane) after Cre excision
of the TrkB.T1 exon. (D) Specific loss of the TrkB.T1 isoform in
whole-brain lysates prepared from 3-month-old TrkB.T12/2 animals.
Western blot analysis using the TrkBout antibody as described in
Experimental Procedures (left panel). The bottom panel shows the
blot stripped and reprobed with an antibody to actin. The right panel
represents a wheat germ agglutin precipitation from whole-brain
lysate, probed with TrkBout. Note the specific loss of the truncated
TrkB receptor. (E) Ratios of full-length TrkB receptors relative to ac-
tin in whole-brain lysates are similar in TrkB.T1+/+ (n = 3) and
TrkB.T12/2 (n = 3) animals. TrkB.T1+/+ is set at 100%. Error bars
indicate SEM. (F) Targeting of TrkB.T1 does not affect expression
of the TrkB kinase receptor in primary astrocyte cultures. Astrocytes
were prepared from E16.5 TrkB.T1+/+, TrkB.T1+/2, and TrkB.T12/2
embryos, lysed, and analyzed by Western blot using the TrkBout an-
tibody (top panel). The bottom panel shows an immunoblot for actin
as a loading control.Results
Selective Deletion of the TrkB.T1 Isoform
To decrease the levels of TrkB.T1, we first used a gene
targeting approach to remove the TrkB.T1 coding
exon, which is located between the juxtamembrane
and the tyrosine kinase coding exons (Figure 1). To avoid
disruption of the full-length TrkB isoform containing the
tyrosine kinase, we inserted loxP sites into the genomic
regions that showed no conservation between the
mouse and human sequence (Figure 1B). We reasoned
that a lack of conservation between the two mammalian
species indicated that these areas are not important for
splicing regulation. The absence of TrkB.T1 in mutant
mice was verified in whole-brain lysates (Figure 1D).
Since a TrkB-specific antibody raised against the extra-
cellular domain showed the presence of a background
band at about the same position on the gel as TrkB.T1,
we prepared whole-brain wheat-germ lysates and
probed with the same antibody. This procedure, which
was used to enrich for glycosylated membrane proteins
such as Trk receptors, eliminated the background band
(Figure 1D, right panel). We next investigated whether
elimination of the genomic sequence between the trans-
membrane and the tyrosine kinase coding exons would
affect the expression of the full-length TrkB receptor
(Figures 1D and 1E). No difference in the level of full-
length TrkB was found between the TrkB.T1 mutant
and control mice, suggesting that targeting of the
TrkB.T1 truncated isoform did not affect the expression
level of full-length TrkB (Figure 1E). To investigate
whether splicing of the different TrkB isoforms was af-
fected by the targeting, we analyzed isoform expression
in cultured primary astrocytes, a cell type that expresses
only truncated TrkB (Rose et al., 2003). Neither full-length
TrkB nor TrkB.T1 expression was noted in astrocytes
from homozygous TrkB.T1 mutant mice, suggesting
that the genomic elements controlling splicing were not
affected. Moreover, we observed a reduction of the
TrkB.T1 receptor level in the heterozygous mutant astro-
cytes, suggesting a potentially useful strategy to correct
TrkB.T1 levels in the Ts16 mouse (Figure 1F).
In Vivo Reduction of TrkB.T1 Restores Ts16
Hippocampal Neuron Survival
To determine whether reducing TrkB.T1 levels would
rescue Ts16 hippocampal neurons from premature
death, we intercrossed TrkB.T1 homozygous mice with
the Robertsonian Ts16 parental strain, which is doubly
heterozygous for chromosomal translocations 6:16
and 16:17 (Gearhart et al., 1986). The resulting progeny
were all heterozygous for TrkB.T1 and were either
euploid or trisomic (monosomic conceptuses are early
embryonic lethal). Cultured hippocampal neurons were
prepared from littermate euploid and trisomic embryos
at day 16.5 (E16.5) and maintained in serum-free me-
dium containing the chemically defined supplement
B27. By the second day in vitro, the cultures consisted
primarily of postmitotic, differentiated neurons with
extensive process formation, as previously described
(Dorsey et al., 2002). At 3 days in vitro, we examined
the levels of TrkB.T1 in hippocampal neurons from the
Ts16 mice heterozygous for TrkB.T1 and found that
TrkB.T1 protein had been reduced to levels
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23indistinguishable from wild-type (Figures 2A and 2B,
lanes 2 and 3). Next, we assayed the survival of the Ts16;
TrkB.T1+/2 hippocampal neurons in vitro. We cultured
hippocampal neurons on gridded glass coverslips and
followed the survival of individual neurons over 7 days
in vitro. Consistent with our previous reports (Bambrick
Figure 2. Reduction of TrkB.T1 Levels in the Ts16 Mouse Restores
Hippocampal Neuron Survival
(A) Deletion of one TrkB.T1 allele restores the physiological level of
TrkB.T1 in Ts16 hippocampal neurons. Neuronal cultures were pre-
pared from E16.5 euploid and Ts16 littermates that were either wild-
type for TrkB.T1 or heterozygous for TrkB.T1. Lysates from neuronal
culture from different genotypes were prepared and analyzed by
Western blot using the antibody TrkBout. The autoradiographs
shown are representative of three independent experiments. (B) De-
letion of one TrkB.T1 allele restores the ratio of TrkB.T1/TrkB full-
length (FL) in Ts16 neurons. Blots were quantified by scanning auto-
radiographs into NIH Image to determine the optical density of each
band. The ratio of the optical density of the TrkB.T1 and TrkB.FL
bands were normalized relative to the intensity of the actin band,
used as loading control, and the ratio obtained from euploid control
neurons was establish to be 1 (lane 2). Values represent the mean6
SEM from three independent sets of neuronal cultures from each ge-
notype. Lane numbers at the bottom are the same as in (A). (C) Cul-
tured hippocampal neurons prepared from E16.5 embryos of the in-
dicated genotypes were assayed for survival over 7 days in vitro as
described in Experimental Procedures. Approximately 400 neurons
for each genotype were analyzed for survival, expressed as a per-
centage of the number of cells at day 2 in vitro. Error bars show
SEM, and the number of embryos analyzed for each genotype is in-
dicated in parenthesis. (D) Phase-contrast images of euploid (Eu),
Ts16, and Ts16;TrkB.T1+/2 (Ts16T1+/2) cultured hippocampal neu-
rons at 6 DIV. Note the extensive fragmented processes and cellular
debris in the Ts16 but not in the Ts16;TrkB.T1+/2 cultures. Scale
bars, 20 um.et al., 1995; Dorsey et al., 2002), about 15% of wild-type,
euploid neurons and 50% of Ts16 neurons died within
7 days (Figure 2C). In contrast, the survival of Ts16 neu-
rons heterozygous for TrkB.T1 was indistinguishable
from wild-type euploid neuron survival, indicating a com-
plete rescue of the premature neuronal death phenotype
(Figure 2C). Interestingly, neurons lacking TrkB.T1 (Fig-
ure 2C, Eu T12/2) had a survival rate similar to that of
control neurons, suggesting that TrkB.T1 per se is not
required for neuron survival.
At day 6 in vitro, in contrast to Ts16;TrkB.T1+/+ neuron
cultures, which exhibited widespread neurite fragmen-
tation and cellular debris, neuron cultures from
Ts16;TrkB.T1+/2 fetuses had complex, nonfragmented
neurites and little or no cellular debris, similar to wild-
type euploid neurons (Figure 2D). These findings sug-
gest that, despite the triplication and probably dysregu-
lation of more than 700 genes on mouse chromosome 16
(Mao et al., 2003), restoring physiological expression
levels of a single gene isoform, TrkB.T1, is sufficient to
rescue the premature hippocampal neuronal cell death
phenotype of Ts16 neurons.
Full-Length TrkB Response to BDNF Is Restored
in Ts16 Neurons by In Vivo Reduction of TrkB.T1
To examine the mechanism underlying the restoration of
Ts16 hippocampal neuron survival, we analyzed the
BDNF-induced phosphorylation of full-length TrkB. We
have previously reported that TrkB phosphorylation is
decreased by w60% in Ts16 neurons compared with
levels in euploid neurons, suggesting that increased
truncated TrkB inhibits TrkB signaling (Figure 3A; Dor-
sey et al., 2002). However, when we reduced the levels
of TrkB.T1 in vivo by deleting one copy of TrkB.T1, the
BDNF-induced phosphorylation of full-length TrkB in
neurons from Ts16 embryos was restored to 85%–
90% of wild-type euploid levels (Figures 3A and 3B).
We next investigated the phosphorylation level of Akt
and Erk, two important downstream proteins of TrkB-
activated signaling cascades (Huang and Reichardt,
2003; Kaplan and Miller, 2000; Figures 3A and 3B). Sur-
prisingly, we found that after treating Ts16 neurons with
BDNF, only Akt phosphorylation was significantly re-
duced to about 70%–75% of that of euploid neurons,
while Erk phosphorylation was not affected by the tripli-
cation of chromosome 16. This intriguing result sug-
gests that TrkB.T1 does not act in a classic dominant-
negative way by reducing the general activation of the
TrkB kinase receptor. Instead, it affects only specific
downstream signaling pathways. Moreover, reduction
of truncated TrkB.T1 to wild-type levels in Ts16 neurons
(Figures 3A and 3B; Ts16T1+/2) normalizes Akt phos-
phorylation levels in response to BDNF, suggesting
that the overexpression of this truncated isoform is in-
deed responsible for the dysregulation of Akt activation.
To investigate whether TrkB.T1 differentially affects sig-
naling to ERK and Akt, we performed a dose-response
analysis of the TrkB kinase-activated signaling path-
ways in neurons lacking TrkB.T1. Neurons from control
and TrkB.T1 mutant embryos were isolated, cultured
for 3 days, starved for 4 hr, and treated with BDNF at
concentrations ranging from 1 to 100 ng/ml. Phosphor-
ylation of the TrkB kinase receptor, as well as Erk and
Akt, was increased in neurons lacking the TrkB.T1
Neuron
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and 3D). However, as observed in Figure 3A, signaling to
Akt appeared to be differentially affected by the loss of
TrkB.T1, since Erk activation was less influenced
by TrkB.T1 deficiency. This suggests that TrkB.T1 selec-
tively modulates signaling to different downstream
Figure 3. Reduction of TrkB.T1 in Ts16 Neurons Restores BDNF-
Induced TrkB Activation and Resting Cytoplasmic Ca2+ Levels
(A) E16.5 hippocampal neuron cultures of the indicated genotypes
were cultured with B27 serum supplement. On the third day
in vitro, the supplement was removed for 4 hr, and neurons were ei-
ther left untreated as controls or treated for 5 min with 100 ng/ml of
BDNF. Lysates were harvested and analyzed by Western blot using
an antibody specific for Trk phosphorylation at the Y515 site (Shc
binding site) or antibodies recognizing the phosphorylated forms
of Akt and Erk. The autoradiographs shown are representative of
three independent sets. (B) Quantification of TrkB, Erk, and Akt ac-
tivation in neurons’ lysates is calculated as the ratio of band intensity
value of phospho-protein and GAPDH where the ratio for euploid
control neurons is set at 100%. Error bars indicate SEM (n = 4). *p
< 0.01 by t test. (C) BDNF dose-response analysis on E16.5 hippoca-
mapl neuron cultures from control (+/+) and TrkB.T12/2 neurons.
Neuronal cultures were prepared and treated with BDNF concentra-
tions ranging from 0 to 100 ng/ml as described in (A). Note the robust
increase in the phosphorylation levels of both TrkB kinase and Akt in
TrkB.T1-deficient neurons compared to the control cultures.
(D) Quantification of phospho TrkB, Erk, and Akt in neurons’ lysates
is calculated as the ratio of band intensity value of phospho-protein
and GAPDH where the ratio for euploid control neurons is set at 1.
Error bars indicate SEM (n = 3). (E) Cytoplasmic Ca2+ is reduced in
hippocampal neurons from Ts16;TrkB.T1+/2mice. Box plots indicate
the 25th, 50th (median), and 75th percentiles of the distribution of
Fura 2 fluorescence emission ratios from euploid (Eu wt, n = 54),
Ts16;TrkB.T1+/+ (Ts 16, n = 64), Ts16;TrkB.T1+/2 (Ts16 T1+/2; n =
47), and TrkB.T12/2 (T12/2; n = 87) neurons obtained from four ani-
mals of the indicated genotypes (N = 4 experiments). Whisker lines
indicate the range from 1% to 99% of the distribution. TheTs16group
is significantly different from all other groups at p < 0.05.pathways (Figures 3C and 3D). Notably, the basal level
of Akt phosphorylation was substantially higher in
TrkB.T1-deficient neurons compared to that observed
in controls, suggesting that TrkB.T1 may serve as a
‘‘brake’’ to prevent unwanted TrkB signaling.
Taken together, these data support the notion that the
overexpression of TrkB.T1 in Ts16 neurons affects full-
length TrkB-activated signal transduction but, surpris-
ingly, this inhibition is selective to specific downstream
signaling molecules. In this respect, it should be noted
that while Erks have been implicated in neuronal survival
and proliferation, Akt phosphorylates several proteins
involved in controlling cell survival (Datta et al., 1999;
Yuan and Yankner, 2000). Thus, changes in Akt phos-
phorylation levels may be in part responsible for the pre-
mature neuronal cell death observed in Ts16 neurons.
Intracellular Cytoplasmic Ca2+ Levels Are Restored
in Ts16;TrkB.T1+/2 Neurons
Ts16 neurons and astrocytes have increased levels of
resting intracellular Ca2+ (Bambrick et al., 1997; Muller
et al., 1997; Schuchmann et al., 1998). Recently, it was
shown that BDNF induces an increase in cytoplasmic
Ca2+ in astroglia. Because cultured glial cells do not ex-
press measurable levels of full-length TrkB, this re-
sponse is mediated by the truncated TrkB.T1 receptor
(Rose et al., 2003). However, in neurons, a physiological
link between the TrkB.T1 and Ca2+ levels is unknown.
Therefore, we investigated whether restoring normal
TrkB.T1 expression would reduce resting Ca2+ levels in
Ts16 neurons. In agreement with previous reports, we
found a small, but significant, increase in resting intracel-
lular Ca2+ levels inTs16 hippocampal neurons (Q = 2.424,
p < 0.05) between 4 and 7 days in vitro (Figure 3E). Inter-
estingly, when TrkB.T1 expression in Ts16 mice was re-
duced to euploid levels, we found a significant decrease
(Q = 5.484, p < 0.05) in intracellular resting levels of cyto-
plasmic Ca2+ (Figure 3E). These data suggest that the
altered Ca2+ homeostasis observed in Ts16 hippocam-
pal neurons is a consequence of TrkB.T1 dysregulation.
Interestingly, complete loss of TrkB.T1 does not affect
resting Ca2+ levels in neurons, suggesting that other
mechanisms are involved in the normal control of this
crucial physiological process (Figure 3E).
Ts16;TrkB.T1+/2 Mouse Brains Have
Normal Levels of Apoptosis
Since correcting truncated TrkB.T1 levels rescues hip-
pocampal neuron accelerated cell death, we next inves-
tigated the physiological relevance of this finding in vivo.
Previous studies have shown that Ts16 embryos have
increased apoptosis in both proliferative and postmi-
totic zones of the developing neocortical wall (Haydar
et al., 2000). Thus, we investigated whether restoration
of physiological levels of TrkB.T1 receptor could rescue
the increased cell death in the cortex of Ts16 mice. For
our analysis, we used two markers of apoptosis: termi-
nal deoxynucleotidyl transferase-mediated biotinylated
UTP nick end labeling (TUNEL) staining and immunocy-
tochemical detection of cleaved (activated) caspase-3
(Figures 4A and 4B). These methods detect different
stages of the apoptosis cascade and therefore provide
reliable quantitative and qualitative information of cell
death. First, we studied cell death occurrence within
Truncated TrkB Causes Neuron Cell Death
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as previously reported, they contained an average of 1.5
TUNEL and cleaved caspase-3 positive neurons per
section while the Ts16 embryos had about four TUNEL
and cleaved caspase-3 positive neurons per section
(Figure 4) (Haydar et al., 2000). In contrast to Ts16 brains,
the average number of TUNEL and cleaved caspase-3
positive neurons per section of the Ts16;TrkB.T1+/2
brains was 1.0 to 1.5, indistinguishable from wild-type
Eu cortices and significantly different from that of Ts16
embryos (Figures 4C and 4D). Taken together, these
results suggest that reducing the expression of TrkB.T1
to physiological levels normalizes the incidence of neu-
ronal cell death in the brains of Ts16 embryos. It should
be noted that, consistent with what has been observed
in isolated hippocampal neurons, complete loss of the
TrkB.T1 receptor does not increase the number of
apoptotic neurons in the embryonic cortex, suggesting
that, also in vivo, TrkB.T1 does not affect directly the
cellular processes that trigger neuronal cell death (Fig-
ures 4C and 4D).
Discussion
In this study, we demonstrate that correcting truncated
TrkB.T1 receptor expression to physiological levels res-
Figure 4. Ts16 Embryos with Reduced TrkB.T1 Levels Have Normal
Cortical Apoptosis Incidence
(A and B) Light microscopy images of 20mm sections from E16.5Ts16
embryos that were either wild-type (A) or heterozygous for TrkB.T1
(B). The tissue sections were processed immunohistochemically
with an antibody directed at cleaved caspase-3. Images in (A) and
(B) are at 1003; scale bar, 100 mm. Inset in (A) is at 2003magnifica-
tion; scale bar, 25 mm. (C and D) Dying cells throughout the cortical
wall of embryos at day 16.5 of development were quantified by
counting cells positive for cleaved caspase-3 (C) or by the TUNEL
method (D) as described in Experimental Procedures. Note that
Ts16 embryos have a 3- to 4-fold increase in the number of apoptotic
cells as previously reported (Haydar et al., 2000). Deletion of one
copy of TrkB.T1 restores the number of apoptotic cells to normal
levels. Data are from two independent sets of animals, one set for
cleaved caspase-3 (n = 4 for each genotype) and one set for the
TUNEL analysis (n = 4 for each genotype). Mean 6 SEM. Data were
analyzed by Student’s t test. *p < 0.05 relative to Eu control embryos.cues the accelerated death of Ts16 hippocampal neu-
rons and normalizes the level of apoptosis in the
cortex of Ts16 fetuses. In turn, rescued neurons show
both an increase in the phosphorylation level of the
TrkB tyrosine kinase receptor and Akt in response to
BDNF and a restoration of intracellular Ca2+ levels.
Alterations in neurotrophins or their Trk receptor
levels have been reported in a variety of neurodegener-
ative diseases, including amyotrophic lateral sclerosis
(ALS) and Alzheimer’s, Huntington’s, and Parkinson’s
diseases (reviewed in Dawbarn and Allen, 2003). How-
ever, it is still unclear whether changes in expression
of these receptors are involved in the pathogenic pro-
cess or are an indirect effect of the disease. A major
problem with testing this hypothesis has been the lim-
ited number of suitable models. Ts16 hippocampal neu-
rons provide a tool to study the genetic abnormalities
underlying neuronal cell death. The cause of the acceler-
ated cell death has the potential to be multigenic, since
hundreds of genes are dysregulated in trisomies (Mao
et al., 2003). Surprisingly, we found that an alteration in
TrkB receptor signaling is sufficient for the development
of this phenotype, suggesting that dysregulation of a sin-
gle gene is sufficient to cause cellular alterations result-
ing in neuron death. It should be noted that since the
TrkB gene is located on mouse chromosome 13 and
consequently not triplicated in Ts16, the altered expres-
sion of TrkB isoforms observed in Ts16 neurons must be
secondary to the increased gene dosage of one or more
chromosome 16 genes.
Expression of TrkB receptor isoforms is dynamically,
yet tightly, regulated during development of the mam-
malian or chicken nervous system, suggesting a critical
role for this receptor. Expression of the full-length TrkB
precedes that of the truncated isoforms (Allendoerfer
et al., 1994; Escando´n et al., 1994). Interestingly, in the
mammalian cortex, the shift to a predominance of trun-
cated TrkB occurs at times that correlate with the onset
of cell death and maturation of axonal connections
(Allendoerfer et al., 1994; Ohira et al., 1999). Thus, imbal-
ances in TrkB receptor isoform levels in pathological
conditions may lead to cell death with a mechanism sim-
ilar to that used during the critical period of cell death
and axonal remodeling associated with the nervous
system developmental plasticity.
Interestingly, we found that TrkB.T1 overexpression
in Ts16 neurons has a selective effect on Akt activation,
a downstream signaling molecule associated with cell
survival, while BDNF stimulation of ERK phosphoryla-
tion is not affected in Ts16 neurons (Kaplan and Miller,
2000). This is a surprising result because it suggests
that truncated TrkB does not affect TrkB signaling
by a simple dominant-negative mechanism of the full-
length receptor. Instead it suggests that truncated
TrkB may affect, in a discrete way, the complex balance
of interactions between the activated full-length TrkB
receptor and the numerous cytoplasmic adaptor pro-
teins involved in transducing its signals (Huang and
Reichardt, 2003; Kaplan and Miller, 2000; Segal, 2003).
In support of this hypothesis is also the finding that,
when TrkB.T1 is completely ablated in neurons, we still
observed a differential effect of signaling to Akt and Erk,
with Akt being more robustly phosphorylated in re-
sponse to BDNF (Figures 3C and 3D). Truncated
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mammalian brain at the time when synaptic transmis-
sion and plasticity and memory formation become key
processes in brain development. Interestingly, BDNF-
activated Erk signaling has been heavily implicated in
these brain activities (Alonso et al., 2002, 2004; Blan-
quet, 2000; Finkbeiner et al., 1997; Gottschalk et al.,
1999; Pizzorusso et al., 2000). Thus, our findings raise
the intriguing possibility that the TrkB.T1 physiological
upregulation in the mammalian brain may be used to
control Akt activation, leaving Erk signaling unaffected
to modulate synaptic plasticity events and memory
formation.
Mice lacking TrkB or its ligand BDNF display a signifi-
cant increase of apoptosis in different areas of the devel-
oping CNS, including the hippocampus, cortex, and cer-
ebellum (Alca´ntara et al., 1997; Minichiello and Klein,
1996; Schwartz et al., 1997). These losses are not severe,
most likely because of the presence of multiple path-
ways promoting the survival of CNS neurons or the com-
pensatory effect of the TrkC receptors that are frequently
coexpressed in neurons of the CNS (Alca´ntara et al.,
1997; Minichiello and Klein, 1996; Miranda et al., 1993).
However, these data are in agreement with the mild,
yet significant, increase of neuronal cell death observed
in the cortex of the Ts16 embryos. In addition, this phe-
notype can be exacerbated by the in vitro culture con-
ditions that can block some of the compensatory mech-
anisms present in vivo. Thus, our data support the notion
that an intact BDNF/TrkB signaling system is required for
the maintenance of CNS neurons and establish TrkB.T1
as a critical player in the tight control of this important
ligand/receptor system.
We previously reported a selective failure of BDNF to
support the survival of Ts16 hippocampal neurons due
to the elevated expression of TrkB.T1 relative to full-
length TrkB and that this defect could be corrected by
overexpressing full-length TrkB (Dorsey et al., 2002).
Now we report that reducing the expression of TrkB.T1
to the level found in euploid neurons can restore
BDNF-induced survival of Ts16 neurons. These data
suggest that neurodegeneration may not only be the re-
sult of a diminished supply of neurotrophins and provide
direct evidence that neurons must express the correct
set of receptor isoforms to transduce a proper survival
signal in response to neurotrophins.
Interestingly, overexpression of truncated TrkB has
also been reported in the hippocampus of human Alz-
heimer’s disease patients (Ferrer et al., 1999), suggest-
ing that a similar mechanism may participate in hippo-
campal neuron degeneration in this disease. Moreover,
in ALS patients, BDNF mRNA and protein are dramati-
cally upregulated in muscle as well as total TrkB mRNA
in the spinal cord (Kust et al., 2002; Mutoh et al., 2000).
Yet, phosphorylation of the TrkB receptor is reduced
(Mutoh et al., 2000). Thus, it is possible that TrkB signal-
ing impairments in ALS are not at the level of neurotro-
phin supply but rather at the level of the TrkB receptor
isoforms being expressed. Determination of truncated
and full-length TrkB receptor ratios should help in identi-
fying whether ALS andTs16neurons have similar deficits
and may help to explain why therapeutic use of BDNF
has been unsuccessful in ALS clinical trials (Ochs et al.,
2000).We have found that, in Ts16 hippocampal neurons,
restoration of physiological levels of TrkB.T1 corrects
resting Ca2+ levels. While it was known that truncated
TrkB alone mediates the regulation of intracellular Ca2+
signaling by BDNF in astrocytes (Rose et al., 2003), the
function of TrkB.T1 in neurons, which express both
full-length and truncated TrkB isoforms, is more com-
plex. Our data suggest that, in neurons, proper TrkB.T1
levels (or the relative proportion of full-length TrkB to
TrkB.T1) are critical for maintaining Ca2+ homeostasis.
Since even small increases in cytoplasmic Ca2+ can
have deleterious consequences, including decreased
neuronal survival (Johnson et al., 1992), it is possible
that the correction in the intracellular Ca2+ level by re-
duction of TrkB.T1 may contribute to the rescue of the
Ts16 accelerated neuronal cell death.
Taken together, our data provide evidence that rela-
tively small imbalances in the physiological levels of
TrkB receptor isoforms affect neuronal survival by alter-
ing both BDNF-induced prosurvival signaling and Ca2+
homeostasis. Moreover, they suggest that the success
of exogenous neurotrophin application to reduce or pre-
vent cell death in neurodegenerative disorders may de-
pend upon the neuron’s ability to properly regulate the
expression of neurotrophin receptor isoforms and, con-
sequently, its survival.
Experimental Procedures
Generation of TrkB.T1 Mutant Mice
The targeting vector to conditionally remove the TrkB.T1-specific
coding exon was constructed by a recombinogenic cloning strategy
(Liu et al., 2003) using a murine BAC clone (RP23 library, Invitrogen).
An upstream loxP site, containing a SpeI (S) restriction site, was
placed 300 bp 50 of the T1 coding sequence. The pGK-neomycin
(NEO) resistant cassette flanked by loxP and frt sites was placed 1
kb 30 of the T1 coding sequence (Figure 1). The targeting vector
was electroporated in the CJ7 embryonic stem cell line (129/sv),
as described (Tessarollo, 2001), and recombinant clones obtained
at a frequency of 1/44 were injected into C57BL/6 blastocysts to pro-
duce chimeras that transmitted the targeted TrkB.T1 allele to the
progeny (Bonin et al., 2001). Following the NEO cassette and the
TrkB.T1 exon removal, breeding of two TrkB.T1+/2 mice gave rise
to homozygous mutants at a frequency of 25%.
Western Blot Analysis
Cells were lysed and analyzed by Western blot analysis as described
(Dorsey et al., 2002). The rabbit polyclonal antibody directed to an
extracellular epitope of TrkB (trkBout) was generously provided by
Dr. Deborah Morrison (NCI-Frederick). The mouse monoclonal
raised to the extracellular TrkB epitope, the polyclonal antibodies
specific for phospho-Trk (#9141), phospho-Akt (#9271), and phos-
pho-MAPK/ERK1/2 (#9106) were obtained from Cell Signaling. The
anti actin (#SC-1616) and GAPDH (MAB374) antibodies were, re-
spectively, from Santa Cruz and Chemicon International. BDNF
was from Upstate Biotechnology. Autoradiographs were scanned
at 600 dpi using a Hewlett-Packard scanner, and quantitation of
band intensity was performed using NIH Image v1.62 (National Insti-
tutes of Health). The activation of TrkB, Akt, and ERK by BDNF was
quantified by calculating the ratios of band intensity of Phospho-
TrkB, Erk, or AKT and band intensity of GAPDH. The values obtained
from eupolid controls were set as 100%.
Generation of Trisomic Mice and Karyotyping
Robertsonian mice (Jackson Laboratory, Bar Harbor, ME) were
mated with wild-type or TrkB.T1 homozygous C57BL/6J mice at
generation N4 to generate wild-type and Ts16 mice heterozygous
for TrkB.T1. The next day was designated as day 0.5 of gestation
(E 0.5). Normal and Ts16 fetuses were easily distinguishable; how-
ever, mice were also karyotyped by fluorescence in situ
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27hybridization (FISH) using probes specific for chromosome(s) 6, 16,
and 17 to confirm visual phenotyping.
Neuron and Astrocyte Cultures
Hippocampal neurons were dissected and cultured from euploid
and Ts16 wild-type and TrkB.T1+/2 E16.5 mice in minimal essential
medium (MEM) and the serum-free supplement B27, as previously
described (Bambrick et al., 1995). Neurons were plated at 104
cells/cm2 on 12 mm glass coverslips etched with a lettered grid (Ep-
pendorf AG, Hamburg, Germany) for survival experiments and at 53
105 cells/35 mm dish for Western blots. Glass coverslips were
coated with poly-L-lysine (Sigma, St. Louis, MO) and mouse laminin.
Plastic dishes were coated with poly-L-lysine alone. The purity of
hippocampal neuron cultures was established by immunostaining
for glial fibrillary acidic protein (GFAP), which revealed no differ-
ences in the proportion of astrocytes (<5%) in euploid and Ts16 cul-
tures (data not shown). Unless otherwise indicated, all cell culture
reagents were obtained from Invitrogen (Carlsbad, CA).
Astrocytes cultures were obtained from E16.5 embryos as de-
scribed previously (Bambrick et al., 1997). Glial fibrillary acidic pro-
tein (GFAP) immunostaining was conducted to verify that the major-
ity (>90%) of cells were astrocytes (data not shown).
Measurement of Neuron Survival
At 2 days in vitro (DIV), all live neurons in each of four randomly se-
lected 175 3 175 mm fields per coverslip (identified by the etched
grid) and at least eight coverslips per genotype (n = 400+) were
counted using phase-contrast microscopy (Dorsey et al., 2002).
Neurons were counted every 24 hr, and survival was expressed as
a percentage of cells present at 2 DIV that remained at 7 DIV. The sig-
nificance of the difference between genotypes was determined by
Student’s t test.
Dye Loading and Fluorescence Measurement
Isolated primary hippocampal neurons were loaded with Fura 2AM
(3 mm; Molecular Probes, Inc., OR) in Physiological Saline Solution
(PSS; NaCL 140 mM, KCl 4.0 mM, CaCl2 1.8 mM, KHrPO4 1.0 mM,
MgCl 1.4 mM, HEPES 10.0 mM, glucose 11.5 mM) for 40 min,
washed twice (10 min) with PSS, and rested for 30 min. Fields of neu-
rons were then imaged (Olym. IX-50; 403 H20 Obj.) with alternating
excitation (340 nm, 380 nm; Sutter DG-4; Chroma filter set) while the
emission at 515 nm was collected (Roper CoolSnap HQ) as de-
scribed previously (Chun et al., 2003). On archived image sequences
(five samples/field; 0.2 Hz) emission ratios (340ex/380ex) were cal-
culated for each neuron following background correction (IPlab
4.1) with the mean ratio used as the value for relative [Ca2+ ]free. Re-
sults are from Eu+/+ (n = 54), Ts16+/+ (n = 64), Ts16;TrkB.T1+/2 (n =
47), and TrkB.T12/2 (n = 87) neurons obtained from at least four an-
imals per genotype (N = 4 experiments). Relative [Ca2+ ]free between
groups was compared using a nonparametric, Kruskal-Wallis analy-
sis of variance on ranks followed by a Dunns post hoc analysis
(Sigma Stat 3.0 ; SPSS Inc.). Significance between groups was eval-
uated at a level of p < 0.05.
Detection and Quantitation of Apoptotic Cells
E16.5 fetal brains were collected, fixed in 4%PFA, and cryopro-
tected in 30% sucrose for cryostat sectioning. Twenty-micron coro-
nal sections taken at approximately 200 mm caudal to the interven-
tricular foramen, where the hippocampus appears (Jacobowitz
and Abbott, 1998; plates 3–5], were analyzed for cell death in the cor-
tical wall (Haydar et al., 2000). Sections to be analyzed for cleaved
caspase-3 (1:100; Cell Signaling) immunohistochemistry analysis,
or apoptosis analysis were processed by the avidin-biotin method
(ABC kits, Vector Labs) or with the ApopTag Peroxidase InSitu Oligo
Ligation Apoptosis detection Kit (Chemicon), respectively. Every
third section was analyzed. Cells were counted from the lateral ven-
tricle to the cortical surface in a 100 mm square located at a consis-
tent position on the dorsal pallium, midway between the medial and
lateral borders of the lateral ventricle following a 2D counting
method (Haydar et al., 1996, 2000). The number of positively stained
cells was expressed as the mean6 SEM per animal and was used as
the unit of data analysis.Acknowledgments
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